SUSTAINED EFFICACY IS ACHIEVED WITH REPEAT COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS (TNF-IR)

被引:0
|
作者
Keystone, Edward C. [1 ]
Fleischmann, Roy M. [2 ]
Emery, Paul [3 ]
Dougados, Maxime [4 ]
Baldassare, Andrew R. [5 ]
Armstrong, Gillian K. [6 ]
Linnik, Matthew [7 ]
Reynard, Mark [6 ]
Tyrrell, Helen [6 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Leeds Gen Infirm, Leeds, W Yorkshire, England
[4] Hop Cochin, F-75674 Paris, France
[5] St Louis Univ, St Louis, MO 63103 USA
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[7] Biogen Idec Inc, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:I98 / I98
页数:1
相关论文
共 50 条
  • [1] SUSTAINED EFFICACY IS ACHIEVED WITH MULTIPLE COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS
    Keystone, Edward
    Fleischmann, Roy
    Emery, Paul
    Dougados, Maxime
    Williams, Sarah
    Reynard, Mark
    RHEUMATOLOGY, 2011, 50 : 121 - 122
  • [2] Multiple Courses of Rituximab (RTX) Produce Sustained Efficacy in Patients (pts) with Rheumatoid Arthritis (RA) with An Inadequate Response (IR) to One or More TNF Inhibitors
    Keystone, Edward
    Fleischmann, R.
    Emery, Paul
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1294 - 1294
  • [3] Repeated treatment courses of rituximab in rheumatoid arthritis: Sustained efficacy in patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Fleischmann, R. M.
    Emery, P.
    Chubick, A.
    Dougadoss, M.
    Baldassare, A. R.
    Bathon, J. M.
    Hessey, E.
    Hagerty, D.
    Coopers, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 432 - 432
  • [4] MULTIPLE COURSES OF RITUXIMAB PRODUCE SUSTAINED EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS
    Keystone, E.
    Nash, P.
    Fleischmann, R.
    Emery, P.
    Dougados, M.
    Hall, S.
    Williams, S.
    Reynard, M.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 18 - 19
  • [5] Repeated treatment courses of rituximab produce sustained efficacy in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors
    Emery, Paul
    Keystone, Edward
    Fleischmann, Roy
    Chubick, Andrew
    Dougados, Maxime
    Baldassare, Andrew
    Bathon, Joan
    Hessey, Eva
    Hagerty, David
    Cooper, Simon
    RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [6] Sustained improvement with repeated courses of rituximab in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors
    Keystone, Edward C.
    Pope, Janet
    Fleischmann, Roy M.
    Emery, Paul
    Chubick, Andrew
    Dougados, Maxime R.
    Baldassare, Andrew R.
    Bathon, Joan M.
    Hessey, Eva
    Hagerty, David
    Cooper, Simon
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1195 - 1195
  • [7] Efficacy of rituximab in active RA patients with an inadequate response to one or more TNF inhibitors
    Kremer, J. M.
    Kvien, T. K.
    Tony, H.
    Tak, P. P.
    Luggen, M.
    Mariette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 40 - 40
  • [8] Efficacy of rituximab in active RA patients with an inadequate response to one or more TNF inhibitors
    Kremer, J. M.
    Tony, H.
    Tak, P. P.
    Luggen, M.
    Manette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 326 - 326
  • [9] Efficacy of rituximab in active RA patients with an inadequate response to one or more TNF inhibitors.
    Kremer, J. M.
    Tony, H. P.
    Tak, P. P.
    Luggen, M.
    Mariette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S247 - S248
  • [10] Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Fleischmann, R.
    Emery, P.
    Chubick, A.
    Dougados, M.
    Baldassares, A. R.
    Bathon, J. M.
    Hessey, E.
    Totoritis, M.
    Cooper, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 323 - 324